[Interval treatment with local corticosteroids and bases]

Area of Science:

• Dermatology
• Pharmacology

Background:

• Fluocinolone acetonide 0.025% (Jellin) is a topical corticosteroid used for various skin conditions.
• Interval therapy aims to reduce side effects and corticosteroid usage compared to conventional application.

Purpose of the Study:

• To compare the efficacy and safety of three different therapeutic models using fluocinolone acetonide 0.025% (Jellin).
• To evaluate conventional therapy, daily interval therapy, and weekly interval therapy for skin conditions.

Main Methods:

• 71 patients with psoriasis, chronic eczema, or neurodermatitis were enrolled.
• Three treatment groups: conventional (Jellin alone), daily interval (alternating Jellin and base), and weekly interval (Jellin for 4 days, base for 3 days).
• Treatment duration was 2-3 weeks.

Main Results:

• Daily interval therapy demonstrated efficacy comparable to conventional therapy.
• Both daily interval and conventional therapies were superior to weekly interval therapy.
• Weekly interval therapy resulted in treatment discontinuation for 2 patients due to insufficient effect.
• Intolerance reactions were minimal, with one case in the conventional therapy group.
• Interval therapy, as expected, reduced side reactions and corticosteroid application amounts.

Conclusions:

• Daily interval therapy offers an effective alternative to conventional fluocinolone acetonide application.
• Interval therapy models can reduce side effects and corticosteroid exposure in dermatological treatments.
• Weekly interval therapy may be less effective for certain patients compared to daily or conventional methods.